Search Results - "Kacso, I. M."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Adiponectin predicts cardiovascular events in diabetes dialysis patients by Kacso, I.M., Potra, A.R., Bondor, C.I., Moldovan, D., Rusu, C., Patiu, I.M., Racasan, S., Orasan, R., Vladutiu, D., Spanu, C., Rusu, A., Nita, C., Moldovan, R., Ghigolea, B., Kacso, G.

    Published in Clinical biochemistry (01-09-2015)
    “…Adiponectin is an insulin-sensitizing, anti-inflammatory adipokine with anti-atherogenic actions in the general population. In dialysis patients it is unclear…”
    Get full text
    Journal Article
  2. 2

    EFFECT OF EXPERIMENTAL DYSGLYCEMIA ON UNDER-CARBOXYLATED OSTEOCALCIN PRODUCTION IN HUMAN PRIMARY OSTEOBLAST-LIKE CELL CULTURES by Kacso, A, Goia-Socol, M, Hazi, G, Tomoaia, G, Kacso, I M, Georgescu, C E

    “…The undercarboxylated form of osteocalcin (ucOC) and osteoprotegerin (OPG) are bone-derived molecules involved in the endocrine crosstalk governing the bone,…”
    Get full text
    Journal Article
  3. 3

    RELATIONSHIP OF OXIDATIVE STRESS TO URINARY ANGIOTENSIN CONVERTING ENZYME 2 IN TYPE 2 DIABETES MELLITUS PATIENTS by Bondor, C I, Potra, A R, Rusu, C C, Moldovan, D, Bolboacă, S D, Kacso, I M

    “…Angiotensin converting enzyme 2 (ACE2) is highly expressed in the kidney and cleaves angiotensin II to Angiotensin (1-7), annihilating the deleterious effects…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Hierarchy of risk factors for chronic kidney disease in patients with type 2 diabetes mellitus by Bondor, C. I., Kacso, I. M., Lenghel, A. R., Muresan, A.

    “…Diabetic kidney disease is a significant complication of type 2 diabetes mellitus and has a significant impact on quality of life and patient survival, both…”
    Get full text
    Conference Proceeding